HF3609 (Legislative Session 94 (2025-2026))
Disallowance of drug manufacturers from restricting delivery of 340B prescription drugs continued, enforcement provided, and expiration date removed.
Related bill: SF3769
AI Generated Summary
Purpose
- The bill aims to protect access to 340B prescription drugs by preventing drug manufacturers from restricting how these drugs are delivered. It also strengthens state enforcement to push back against such restrictions and removes a sunset expiration that previously limited the rule.
Main provisions
- Adds new Subdivision 4 to Minnesota Statutes 2024 section 62J.96, stating that a violation of the section is considered an unfair or deceptive trade practice.
- Allows the attorney general to enforce this provision, making violations subject to existing consumer-protection enforcement.
- Repeals Minnesota Statutes 2024 section 62J.96 subdivision 3, which previously included an expiration provision related to access to 340B drugs.
- Repeal includes removing the expiration date that existed (expiration was July 1, 2027).
What this changes in law
- Drug manufacturers are prohibited from restricting delivery of 340B drugs covered under the statute.
- Violations can be treated as deceptive trade practices, expanding potential remedies and enforcement options under consumer-protection laws.
- The previous expiration date for the relevant provisions is removed, making the protections for 340B drug access ongoing rather than time-limited.
Enforcement and penalties
- Violations are enforceable by the attorney general.
- The bill treats violations as unfair or deceptive trade practices under the state’s consumer-protection framework, which can lead to AG-led enforcement actions and potential remedies available for deceptive practices.
Expiration and repeal details
- Subdivision 3, which previously contained an expiration (expired July 1, 2027), is repealed.
- By removing the expiration, the new provisions are designed to be ongoing, rather than sunset-limited.
Potential impact
- Hospitals, clinics, and patients who rely on 340B drugs may gain greater assurance that manufacturers cannot block or unduly limit access to these discounted medicines.
- The state’s attorney general gains a clearer authority to pursue and remedy restrictions on 340B drug delivery as part of consumer protection.
Relevant Terms 340B drugs, access to 340B drugs, drug manufacturers, delivery, distribution, unfair or deceptive trade practice, deceptive trade practice, attorney general, Minnesota Statutes 62J.96, Subd.4, Subd.3 Expiration, expiration date, July 1, 2027, enforcement, consumer protection, health care.
Bill text versions
- Introduction PDF PDF file
Past committee meetings
- Health Finance and Policy on: March 18, 2026 13:00
Actions
| Date | Chamber | Where | Type | Name | Committee Name |
|---|---|---|---|---|---|
| February 23, 2026 | House | Action | Introduction and first reading, referred to | Health Finance and Policy | |
| February 25, 2026 | House | Action | Author stricken | ||
| February 26, 2026 | House | Action | Authors added | ||
| March 02, 2026 | House | Action | Author added | ||
| March 05, 2026 | House | Action | Author added | ||
| March 12, 2026 | House | Action | Author stricken | ||
| March 12, 2026 | House | Action | Authors added | ||
| March 16, 2026 | House | Action | Author added | ||
| March 18, 2026 | House | Action | Author added |
Citations
[
{
"analysis": {
"added": [
"Subdivision 4: Violation as deceptive practice; explicitly considered an unfair or deceptive trade practice under section 8.31, subdivision 1; enforceable by the attorney general."
],
"removed": [],
"summary": "Adds a new subdivision to section 62J.96 designating violations of this section as unfair or deceptive trade practices and making them enforceable by the attorney general under Minnesota Statutes 8.31, subdivision 1.",
"modified": [
"Amends section 62J.96 by adding a new subdivision to address enforcement and deceptive-practice designation."
]
},
"citation": "Minnesota Statutes 2024 section 62J.96",
"subdivision": "Subd. 4"
},
{
"analysis": {
"added": [],
"removed": [
"Subdivision 3 of section 62J.96 is repealed."
],
"summary": "Repeals subdivision 3 of section 62J.96.",
"modified": []
},
"citation": "Minnesota Statutes 2024 section 62J.96",
"subdivision": "Subd. 3"
},
{
"analysis": {
"added": [],
"removed": [],
"summary": "Used to anchor the enforcement framework by describing unfair or deceptive trade practices, referenced in relation to the new Subd. 4 in 62J.96.",
"modified": []
},
"citation": "Minnesota Statutes 2024 section 8.31",
"subdivision": "Subd. 1"
}
]Progress through the legislative process
In Committee
Sponsors
- Rep. Paul Anderson (R)
- Rep. Jeff Backer (R)
- Rep. Ned Carroll (DFL)
- Rep. Gregory Davids (R)
- Rep. Steve Gander (R)
- Rep. Dawn Gillman (R)
- Rep. Kristi Pursell (DFL)
- Rep. Kari Rehrauer (DFL)
- Rep. Liz Reyer (DFL)
- Rep. Joe Schomacker (R)
- Rep. Peter Johnson (DFL)
- Rep. Heather Keeler (DFL)
- Rep. Bernie Perryman (R)
- Rep. Roger Skraba (R)
- Rep. Chris Swedzinski (R)
- Rep. Cal Warwas (R)
- Rep. Natalie Zeleznikar (R)
- Rep. Erin Koegel (DFL)
- Rep. Matt Norris (DFL)